• Board of Directors

    Gary Crocker
    Crocker Ventures
    Gary Crocker served as a member of Merrimack Pharmaceuticals board since 2004 and is currently Chairman of the Board for UofU CMI. Mr. Crocker is President and Managing Director of Crocker Ventures, a privately-held life science investment firm funding differentiated biotechnology and medical device companies. He has held senior executive and board positions with several life science companies including ARUP, Theratech and Research Medical. Mr .Crocker holds an MBA from Harvard Business School.
    Ivy Estabrooke
    USTAR
    Executive Director
    Dr. Estabrooke was appointed USTAR Executive Director, May 2014. Previously, she served as program officer for basic research in Expeditionary Maneuver Warfare & Combating Terrorism Dept at the Office of Naval Research. Dr. Estabrooke is a cognitive neuroscientist by training, with technical expertise in psycholinguistics, pharmacological interventions and statistical modeling. She earned her PhD in neuroscience from Georgetown University adn MS from Eisenhower School of National Defense Univ.
    Robert Etherington
    Clene Nanomedicine, Inc.
    CEO and President
    Rob Etherington has held a variety of roles in 20+ years in the pharmaceutical industry. Rob is former senior VP, commercial operations at Actelion Pharmaceuticals US, Inc. helping grow it into a $7+ billion market-cap company with nearly $2 billion in annual sales. Rob also served as an officer of Actelion and on the US Executive Board. Before joining Actelion, Rob served as a marketing leader at Pfizer with key responsibilities in the launch years for Lipitor and Rezuliin. Rob is an alumnus of the Harvard Business School General Management Program, and he holds an MBA from the Marriott School at Brigham Young University. He joined BioUtah's Board of Directors in April 2016.  
    Val Hale
    Governor's Office of Economic Development
    GOED Executive Director
    Val Hale was appointed as Executive Director of Utah Governor's Office of Economic Development in 2014. Previously, Hale served two years as President & CEO of the Utah Valley Chamber of Commerce. Prior to the chamber, Hale has served in multiple positions at UVU and assisted in transitioning Utah Valley State College to UVU. Additionally, he worked 22 years for BYU Athletic Department. Mr Hale received his bachelor's degree in public relations and a master's in Communications - both from BYU.
    George Hamilton
    Intermountain Healthcare
    Vice President Business Development
    George Hamilton, Intermountain Healthcare - Chairman of BioUtah Board of Directors Mr. George Hamilton serves as Vice President of Business Development for Intermountain Healthcare and provides multifaceted expertise to BioUtah as Vice Chairman of the Board.. From a community entrepreneurial investment arm, Mr. Hamilton leads a variety of innovative projects designed to benefit Intermountain's patients and stakeholders, and to drive growth in Utah's economy life science community.
    Richard Ji
    BD Medical
    Vice President
    Richard Ji is VP of Infusion Therapy Systems at Becton, Dickinson & Co. He has global responsibility for the Infusion Therapy Business, which is a significant portion of the $2.3 billion Medical Surgical Unit. He joined BD close to 20 years ago. His experiences range from managing start-up operations, shutdown operations; productions early in their life cycles to products late in their lifecycles; and turnaround situations. Richard holds a Bachelor of Science in Manufacturing Engineering from Brigham Young University and a MBA from Duke University – Fuqua School of Business. His wife Karen and he have 3 children. He joined BioUtah’s Board in April 2016.
    John Knorpp
    Merit Medical Systems, Inc.
    Chief Regulatory Affairs Officer
    John Knorpp is Chief Regulatory Affairs Officer at Merit Medical Systems. In this role, he directs all global Regulatory and Medical Affairs activities which includes worldwide regulatory submissions and clinical trials. John completed a Bachelor's of Science degree at Brigham Young University specializing in Statistics- Quality Science and an MBA from the University of Utah. Previously he was employed by CR Bard as Director of Regulatory. He has been in the medical device industry since 1996.
    John Langell
    University of Utah
    John Langell, MD, PhD, MPH completed his surgical training at Stanford University Medical Center and completed advanced training in Space and Aerospace Medicine with NASA at the Johnson Space Center in Houston, TX. He has specialized expertise in the treatment of diseases of the upper gastrointestinal tract, biliary tract and endocrine system. He currently serves as Chief of General Surgery at the George E Wahlen VA Medical Center and Executive Director for the CMI at the University of Utah.
    Dirksen Lehman
    Edwards Lifesciences LLC
    Corporate Vice President, Public Affairs
    Dirksen J. Lehman has been corporate vice president, public affairs, since June 2013. He joined the company in 2007 as vice president of government affairs, and later added responsibility for global health economics and reimbursement. In his current role, Lehman continues to oversee these functions and also has responsibility for global communications, corporate branding, and global corporate giving. Prior to joining Edwards, he was head of the healthcare practice at Clark & Weinstock, a government affairs and crisis management consulting firm in Washington, D.C. Lehman has also served in The White House as special assistant to the president for legislative affairs, and health counsel for the majority on the U.S. Senate HELP Committee. Lehman received his undergraduate degree from Millersville University of Pennsylvania and his law degree from Catholic University of America.
    Richard ''Rich'' Linder
    CoNextions Medical
    Rich Linder, CoNextions Medical - Chairman of BioUtah Board of Directors Mr. Linder began his career in the medical device industry in 1991 with Merit Medical Systems. In 1996, Mr. Linder co-founded Rubicon Medical, Inc. and served as its President and Chief Executive Officer, eventually taking Rubicon public. In 2005, Boston Scientific acquired Rubicon Medical, and Mr. Linder worked for Boston Scientific until leaving in 2006 to become President/CEO and Director of Coherex Medical.
    Kimberly Linthicum
    Myriad Genetics
    Vice President of Government Affairs
    Kim has two decades of government and policy experience in the life science industry. She joined Myriad in 2011 to build a Government Affairs Department. As VP of Government Affairs, Kim oversees their federal and state government affairs and policy activities. Prior to Myriad, Kim spent ten plus years in federal government affairs for various life science organizations including Eli Lilly, Amgen, OSI Pharmaceuticals and PhRMA. She received her bachelor degree from Franklin & Marshall College.
    Jerold Oldroyd
    Ballard Spahr
    Partner
    As partner in one of the state's most prestigous law firms, Jerry Oldroyd concentrates on communications and government affairs, including advising clients on the regulatory, legislative and municipal aspects of telecommunications law. In that capacity, he is experienced in negotiating and drafting interconnection, colocation, franchise and other business agreements. Mr. Oldroyd graduated from the University of Utah (BS 1972, Magna cum laude) and University of Utah, SJ Quinney College of Law.
    Dinesh Patel
    Dinesh and Kalpana Patel Foundation
    Dr. Dinesh Patel is a Managing Director of Patel Family Investments, a venture capital fund. Previously, Dr. Patel served as President & CEO of TheraTech, Inc. He has founded/co-founded several companies including Ashni Naturaceuticals, Salus Therapeutics and OneCare. Dr Patel has been the recipient of multiple awards including BioUtah's Willem J. Kolff Lifetime Achievement Award. He was on the USTAR Governing Authority and currently is Chairman of the Board at The Leonardo.
    Travis Sessions
    Biomerics
    CEO
    Travis Sessions is the Founder, President & CEO of Biomerics. With over 19 years experience in business management, Mr. Sessions has successfully built multiple medical device technology companies and held key management positions at Biosonix, Microsoft, The Dow Chemical Company and Parker Hannifin Corp. He has a BS in Chemical Engineering from BYU and MBA from the University of Michigan. He serves on various industry boards as well as the Salt Lake Life Science Angels and private education organizations.
    John Stillings
    Zions Bank
    John Stillings is executive vice president of Commercial Lending for Zions Bank. His division is responsible for the origination of commercial credit, servicing of individual loan portfolios, and developing and deepening corporate relationships. He oversees nine distinct credit regions throughout the Utah and Idaho footprint. He also sits on the bank's Senior Loan Committee and Executive Committee. Mr. Stillings graduated from the University of California at Berkeley with a degree in finance.